 |
|
|
| 12/06/2012 |
|
DURECT Announces Pricing of Public Offering of Common Stock |
|
| 11/13/2012 |
|
DURECT to Participate in Upcoming Healthcare Conferences |
|
| 11/05/2012 |
|
DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs |
|
| 10/30/2012 |
|
DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call |
|
| 08/21/2012 |
|
DURECT to Participate in Upcoming Healthcare Conferences |
|
| 08/06/2012 |
|
DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs |
|
| 08/06/2012 |
|
DURECT Announces Intent to Submit NDA for POSIDUR™ for Post-Operative Analgesia |
|
| 07/26/2012 |
|
DURECT Corporation Invites You to Join its Second Quarter 2012 Earnings Conference Call |
|
| 05/03/2012 |
|
DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology |
|
| 05/03/2012 |
|
DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology |
|
| 04/25/2012 |
|
DURECT Corporation Invites You to Join its First Quarter 2012 Earnings Conference Call |
|
| 03/29/2012 |
|
DURECT Receives Back U.S. and Canadian Product Rights to POSIDUR™ |
|
| 03/01/2012 |
|
DURECT Corporation Announces Fourth Quarter and Year End 2011 Financial Results |
|
| 02/24/2012 |
|
DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference Call |
|
| 02/23/2012 |
|
DURECT to Participate in Upcoming Healthcare Conferences |
|
| 02/07/2012 |
|
DURECT to Present at the BIO CEO & Investor Conference |
|
| 01/30/2012 |
|
DURECT Receives Back European Product Rights to POSIDUR™ |
|
| 01/05/2012 |
|
DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial) |
|
| 01/05/2012 |
|
Durect Corp to Discuss POSIDUR Clinical Trial Results |
|
| 11/07/2011 |
|
DURECT Corporation to Participate in Upcoming Healthcare Conferences |
|
| 11/03/2011 |
|
DURECT Corporation Announces Third Quarter 2011 Financial Results and Update of Programs |
|
| 10/26/2011 |
|
DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call |
|
| 09/10/2011 |
|
DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR(R) (BESST) |
|
| 09/06/2011 |
|
DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST) |
|
| 08/31/2011 |
|
DURECT Corporation to Participate in Upcoming Healthcare Conferences |
|
| 08/04/2011 |
|
DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs |
|
| 07/28/2011 |
|
DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call |
|
| 07/12/2011 |
|
Zogenix and DURECT Announce Development and License Agreement for Antipsychotic Product Candidate |
|
| 06/24/2011 |
|
Pfizer Receives Complete Response Letter from FDA for REMOXY® |
|
| 06/03/2011 |
|
DURECT to Present at the Jefferies Healthcare Conference |
|
| 06/02/2011 |
|
DURECT Announces Resignation of Chief Medical Officer |
|
| 05/12/2011 |
|
DURECT to Present at the UBS Global Specialty Pharmaceuticals Conference |
|
| 05/05/2011 |
|
DURECT Corporation Announces First Quarter 2011 Financial Results and Update of Programs |
|
| 04/28/2011 |
|
DURECT Corporation Invites You to Join its First Quarter 2011 Earnings Conference Call |
|
| 04/11/2011 |
|
DURECT Announces ELADUR(R) (TRANSDUR(R)-Bupivacaine) Phase II Study Results in Chronic Low Back Pain |
|
| 03/02/2011 |
|
DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial Results |
|
| 03/01/2011 |
|
DURECT to Present at Cowen and Company Health Care Conference |
|
| 02/24/2011 |
|
DURECT Corporation Invites You to Join its Fourth Quarter 2010 Earnings Conference Call |
|
| 02/09/2011 |
|
DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR(TM) (SABER(TM)-Bupivacaine) and Amendment of the Nycomed Agreement |
|
| 02/08/2011 |
|
DURECT Announces Launch of First FDA Approved SABER(TM)-Injectable Peptide Product |
|
| 02/07/2011 |
|
DURECT to Present at the BIO CEO & Investor Conference |
|
| 01/27/2011 |
|
REMOXY(R) New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 |
|
| 12/27/2010 |
|
REMOXY(R) New Drug Application Resubmitted |
|
| 11/22/2010 |
|
DURECT to Present at the Piper Jaffray 2010 Health Care Conference |
|
| 11/08/2010 |
|
DURECT to Present at the Credit Suisse 2010 Healthcare Conference |
|
| 11/03/2010 |
|
DURECT Corporation Announces Third Quarter 2010 Financial Results |
|
| 11/02/2010 |
|
DURECT Awarded $733,438 in Grants Under the Patient Protection and Affordable Care Program |
|
| 10/27/2010 |
|
DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call |
|
| 09/07/2010 |
|
DURECT Corporation to Participate in Upcoming Healthcare Conferences |
|
| 08/04/2010 |
|
DURECT Corporation Announces Second Quarter 2010 Financial Results |
|
| 07/29/2010 |
|
DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call |
|
| 07/28/2010 |
|
DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference |
|
| 07/01/2010 |
|
DURECT Corporation Secures $50 Million Committed Equity Financing Facility |
|
| 06/16/2010 |
|
DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine) |
|
| 06/07/2010 |
|
DURECT Corporation Invites You to Join a Conference Call Today Regarding its POSIDUR(TM) Collaboration with Hospira |
|
| 06/07/2010 |
|
Hospira and DURECT Sign Agreement to Develop and Commercialize POSIDUR™(SABER™-Bupivacaine) in the U.S. and Canada |
|
| 06/01/2010 |
|
DURECT to Present at the Jefferies Global Life Sciences Conference |
|
| 05/13/2010 |
|
DURECT to Present at the Rodman & Renshaw Global Healthcare Conference |
|
| 05/10/2010 |
|
DURECT Corporation Announces First Quarter 2010 Financial Results |
|
| 05/04/2010 |
|
DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call |
|
| 04/07/2010 |
|
DURECT Corporation Announces Commencement of Phase IIb ELADUR(TM) (TRANSDUR(TM)-Bupivacaine) Clinical Trial by King Pharmaceuticals |
|
| 03/18/2010 |
|
DURECT Corporation Appoints Dr. Terrence F. Blaschke to Its Board of Directors |
|
| 03/17/2010 |
|
DURECT to Present at the Barclays Capital Global Healthcare Conference |
|
| 03/01/2010 |
|
DURECT to Present at the Cowen and Company Healthcare Conference |
|
| 02/24/2010 |
|
DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results |
|
| 02/22/2010 |
|
DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory |
|
| 02/17/2010 |
|
DURECT Corporation Invites You to Join Its Fourth Quarter 2009 Earnings Conference Call |
|
| 01/19/2010 |
|
DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial |
|
| 12/17/2009 |
|
DURECT Reports Positive Phase IIb Data from POSIDUR(TM) Clinical Program |
|
| 11/23/2009 |
|
DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference |
|
| 10/29/2009 |
|
DURECT Corporation Announces Third Quarter 2009 Financial Results |
|
| 10/26/2009 |
|
DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call |
|
| 09/17/2009 |
|
DURECT Corporation to Participate in Upcoming Healthcare Conferences |
|
| 09/11/2009 |
|
DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million |
|
| 08/27/2009 |
|
DURECT Signs Long Term Excipient Supply Agreement With King Pharmaceuticals for REMOXY(R) |
|
| 08/18/2009 |
|
DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma |
|
| 08/03/2009 |
|
DURECT Corporation Announces Second Quarter 2009 Financial |
|
| 07/28/2009 |
|
DURECT to Present at the BMO Capital Markets Healthcare Conference |
|
| 07/27/2009 |
|
DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call |
|
| 07/07/2009 |
|
REMOXY® NDA Update |
|
| 06/16/2009 |
|
DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy |
|
| 05/06/2009 |
|
DURECT Corporation Announces First Quarter 2009 Financial Results |
|
| 04/28/2009 |
|
DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call |
|
| 03/16/2009 |
|
DURECT Reports Positive Phase IIb Data from TRANSDUR™-Sufentanil Clinical Program |
|
| 03/09/2009 |
|
DURECT to Participate in Cowen and Company Healthcare Conference |
|
| 02/27/2009 |
|
Endo Pharmaceuticals Returns Product Rights to TRANSDUR™-Sufentanil to DURECT |
|
| 02/09/2009 |
|
DURECT Corporation Announces Fourth Quarter and Year End 2008 Financial Results |
|
| 02/02/2009 |
|
DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call |
|
| 11/03/2008 |
|
DURECT Corporation Announces Third Quarter 2008 Financial Results |
|
| 10/27/2008 |
|
DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call |
|
| 09/22/2008 |
|
Alpharma to Develop and Commercialize DURECT’s ELADUR™ Pain Patch |
|
| 08/27/2008 |
|
DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication based on its ORADUR™ Technology |
|
| 08/12/2008 |
|
REMOXY® NDA Filing Accepted by FDA and Priority Review Granted |
|
| 08/06/2008 |
|
DURECT Corporation Announces Second Quarter 2008 Financial Results |
|
| 07/30/2008 |
|
DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call |
|
| 06/30/2008 |
|
ELADUR™ Development Update: DURECT Receives Orphan Drug Designation of Bupivacaine for Post-Herpetic Neuralgia |
|
| 06/17/2008 |
|
DURECT’s Convertible Notes Exchange into Equity at Maturity |
|
| 06/10/2008 |
|
New Drug Application Submitted for Remoxy™ (ORADUR™-based oxycodone) |
|
| 06/06/2008 |
|
DURECT Corporation to Participate in Upcoming Healthcare Conferences |
|
| 05/21/2008 |
|
DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference |
|
| 05/07/2008 |
|
DURECT Corporation Announces First Quarter 2008 Financial Results |
|
| 04/29/2008 |
|
DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call |
|
| 04/22/2008 |
|
DURECT to Participate in Morgan Stanley Global Healthcare Conference |
|
| 04/07/2008 |
|
DURECT Provides Update on CHRONOGESIC® Research Program |
|
| 03/11/2008 |
|
DURECT to Participate in Cowen Annual Healthcare Conference |
|
| 02/29/2008 |
|
DURECT to Participate in Susquehanna Financial Healthcare Conference |
|
| 02/05/2008 |
|
DURECT to Present at BIO CEO Investor Conference 2008 |
|
| 02/05/2008 |
|
DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results |
|
| 01/31/2008 |
|
DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call |
|
| 12/18/2007 |
|
DURECT Announces Positive ELADUR™ Phase IIa Study Results |
|
| 12/06/2007 |
|
Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy™ |
|
| 12/04/2007 |
|
DURECT to Present at Upcoming Conferences |
|
| 11/20/2007 |
|
DURECT TO PRESENT AT PIPER JAFFRAY HEALTHCARE CONFERENCE |
|
| 11/01/2007 |
|
DURECT Corporation Announces Third Quarter 2007 Financial Results |
|
| 11/01/2007 |
|
DURECT to Present at Upcoming Conferences |
|
| 10/31/2007 |
|
DURECT Corporation Invites You to Join Its Third Quarter 2007 Earnings Conference Call |
|
| 10/17/2007 |
|
DURECT to Host Webcast in Conjunction with an Analyst’s Day on October 17 |
|
| 09/26/2007 |
|
DURECT To Present At UBS Global Life Sciences Conference |
|
| 09/11/2007 |
|
DURECT To Present At Merriman Curhan Ford’s Annual Investor Summit |
|
| 08/31/2007 |
|
DURECT Corporation To Present At The NewsMakers In The Biotech Industry Investment Conference |
|
| 08/07/2007 |
|
DURECT Corporation Announces Second Quarter 2007 Financial Results |
|
| 07/31/2007 |
|
DURECT Corporation Invites You to Join Its Second Quarter 2007 Earnings Conference Call on the Web |
|
| 07/17/2007 |
|
DURECT Reports Positive Results from POSIDUR™ Phase IIb Hernia Trial, Triggering $8 million Milestone Payment from Nycomed |
|
| 07/11/2007 |
|
Patient Recruitment Completed for Pivotal Phase III Study of Remoxy™ |
|
| 06/27/2007 |
|
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals |
|
| 06/21/2007 |
|
DURECT Corporation Presenting at the Jefferies Healthcare Conference |
|
| 06/11/2007 |
|
DURECT Corporation Presenting at the Sixth Annual Needham Biotechnology and Medical Technology Conference |
|
| 05/17/2007 |
|
DURECT Provides an Update to the Memryte™ Program Under Development by Voyager Pharmaceutical Corp |
|
| 05/08/2007 |
|
DURECT Corporation Presenting at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference |
|
| 05/07/2007 |
|
DURECT Corporation Announces First Quarter 2007 Financial Results |
|
| 05/01/2007 |
|
DURECT Corporation Presenting at the 2007 UBS Global Generic and Specialty Pharmaceuticals Conference |
|
| 04/30/2007 |
|
DURECT Corporation Invites You to Join Its First Quarter 2007 Earnings Conference Call on the Web |
|
| 04/09/2007 |
|
DURECT Corporation Presenting at the CIBC Biotechnology & Specialty Pharmaceuticals Conference |
|
| 02/28/2007 |
|
DURECT Corporation to Participate in Upcoming Healthcare Conferences |
|
| 02/12/2007 |
|
DURECT Corporation Presenting at the BIO CEO and Investor Conference |
|
| 02/08/2007 |
|
DURECT Corporation Announces Fourth Quarter and Year End 2006 Financial Results |
|
| 02/05/2007 |
|
DURECT Establishes Corium as Manufacturer of TRANSDUR™-Bupivacaine |
|
| 01/30/2007 |
|
DURECT Corporation Invites You to Join its Fourth Quarter and Year-End 2006 Conference Call on the Web |
|
| 01/29/2007 |
|
DURECT Signs POSIDUR™ Manufacturing Agreement with Hospira |
|
| 01/24/2007 |
|
DURECT Amends Agreement with Voyager Governing Memryte™ |
|
| 01/03/2007 |
|
DURECT Starts Phase II Dosing for TRANSDUR™-Bupivacaine (DUR-843) |
|
| 12/18/2006 |
|
DURECT Corporation Appoints Dr. Terrence F. Blaschke to its Board of Directors |
|
| 12/11/2006 |
|
DURECT Corporation Announces Positive Phase I Study Results with New Product in Development |
|
| 11/30/2006 |
|
Positive Phase I Results Reported for DURECT’s Second Abuse-Resistant Opioid Pain Medicine |
|
| 11/29/2006 |
|
DURECT and Nycomed Sign $202 Million Agreement to Develop and Commercialize POSIDUR™ in Europe and Other Select Countries |
|
| 11/03/2006 |
|
DURECT Corporation Announces Third Quarter 2006 Financial Results |
|
| 10/31/2006 |
|
DURECT Corporation to Present at Upcoming Conferences |
|
| 10/27/2006 |
|
DURECT Corporation Invites You to Join its Third Quarter 2006 Conference Call on the Web |
|
| 10/19/2006 |
|
DURECT Provides an Update to the Memryte™ Program Under Development by Voyager Pharmaceutical Corp. |
|
| 10/16/2006 |
|
DURECT Corporation Presenting at BIO InvestorForum 2006 |
|
| 09/21/2006 |
|
DURECT Corporation Presenting at the UBS Global Life Sciences Conference |
|
| 09/12/2006 |
|
DURECT Corporation Appoints Matthew J. Hogan as Chief Financial Officer |
|
| 08/04/2006 |
|
DURECT Corporation Presenting at the Securities Research Associates Technology Conference |
|
| 08/02/2006 |
|
ORADUR(TM) Technology Milestone: New ORADUR-based Investigational Drug Candidate Commences Phase I Clinical Program |
|
| 07/27/2006 |
|
DURECT Corporation Announces Second Quarter 2006 Financial Results |
|
| 07/19/2006 |
|
DURECT Corporation Invites You to Join its Second Quarter 2006 Conference Call on the Web |
|
| 07/10/2006 |
|
DURECT Corporation to Present at Upcoming Life Sciences Conferences |
|
| 06/23/2006 |
|
DURECT Corporation Presenting at the Jefferies Life Sciences Conference |
|
| 06/12/2006 |
|
DURECT Corporation Presenting at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference |
|
| 05/12/2006 |
|
DURECT Corporation Presenting at the Rodman & Renshaw 3rd Annual Global Healthcare Conference |
|
| 05/05/2006 |
|
ORADUR™ Technology Milestone: Remoxy™ (ORADUR-based oxycodone) Commences Pivotal Phase III Program |
|
| 05/02/2006 |
|
DURECT Corporation Appoints Peter Langecker Chief Medical Officer |
|
| 05/02/2006 |
|
DURECT Corporation Announces First Quarter 2006 Financial Results |
|
| 04/27/2006 |
|
DURECT Provides An Update On Its Post-Operative Pain Depot (SABER™-Bupivacaine) Program |
|
| 04/25/2006 |
|
DURECT Corporation Invites You to Join its First Quarter 2006 Conference Call on the Web |
|
| 04/19/2006 |
|
DURECT Corporation Presenting at the UBS Global Specialty Pharmaceuticals Conference |
|
| 03/30/2006 |
|
DURECT Corporation Presenting at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference |
|
| 02/17/2006 |
|
ORADUR™ Technology Milestone: Remoxy™ (ORADUR-based oxycodone) Receives Special Protocol Assessment and Commences Pivotal Phase III |
|
| 02/10/2006 |
|
DURECT Corporation Presenting at the BIO CEO and Investor Conference |
|
| 02/08/2006 |
|
DURECT Corporation Announces Anticipated Development Program Milestones for Fiscal Year 2006 |
|
| 02/08/2006 |
|
DURECT Corporation Reports Fourth Quarter and Year End 2005 Financial Results |
|
| 01/26/2006 |
|
DURECT to Expand Clinical Program to Additional Surgical Procedures and to Initiate U.S. Clinical Studies and for its Post-Operative Pain Relief Depot |
|
| 01/23/2006 |
|
DURECT Corporation Invites You to Join its Fourth Quarter and Year-End 2005 Conference Call on the Web |
|
| 01/06/2006 |
|
DURECT Announces Promotions and Management Changes |
|
| 01/03/2006 |
|
DURECT Corporation Presenting at the JPMorgan 24th Annual Healthcare Conference |
|
| 12/26/2005 |
|
DURECT Announces Positive Preliminary Results from Transdermal Sufentanil Patch Study in Patients |
|
| 11/11/2005 |
|
DURECT Highlights Major Commercial Strategic Alliance for ORADUR™ Sustained Release Oral Gel-cap Technology |
|
| 11/04/2005 |
|
DURECT Corporation Presenting at the Sixteenth Annual CIBC Healthcare Conference |
|
| 11/03/2005 |
|
DURECT Corporation Presenting at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference |
|
| 11/02/2005 |
|
DURECT Corporation Announces Pricing of Public Offering |
|
| 10/27/2005 |
|
DURECT Corporation Announces Proposed Public Offering of Common Stock |
|
| 10/18/2005 |
|
DURECT Announces Positive Preliminary Results from its Phase II Study for its Post-Operative Pain Relief Depot |
|
| 10/14/2005 |
|
DURECT Corporation Announces Initiation of Dosing for Phase III Clinical Program for Memryte (DURIN™-Leuprolide Implant) Program Under Development with Voyager Pharmaceuticals |
|
| 10/13/2005 |
|
DURECT Corporation Announces Third Quarter 2005 Financial Results |
|
| 10/07/2005 |
|
DURECT Corporation Invites You to Join its Third Quarter 2005 Conference Call on the Web |
|
| 09/21/2005 |
|
DURECT To Present Preliminary Phase II Clinical Data for Cohort 3 for its Post-Operative Pain Relief Depot at American College of Surgeons Conference |
|
| 09/19/2005 |
|
DURECT Corporation Announces Completion of Dosing in Cohort 3 of its Phase II Study for its Post-Operative Pain Relief Depot |
|
| 09/09/2005 |
|
DURECT Corporation Announces Positive Phase III Clinical Results for Remoxy, a Novel Oral Pain Medication using the ORADUR™ Gel-Cap |
|
| 08/08/2005 |
|
DURECT Corporation Presenting at Summer Tech Fest 2005 Investor Conference Hosted by C.E. Unterberg Towbin and Security Research Associates |
|
| 08/01/2005 |
|
DURECT Corporation Presenting at the Adams Harkness & Hill Annual Summer Seminar |
|
| 07/22/2005 |
|
DURECT Plans to Reduce Convertible Debt Balance by $5 Million |
|
| 07/22/2005 |
|
DURECT Corporation Announces Second Quarter 2005 Financial Results |
|
| 07/12/2005 |
|
DURECT Corporation Presenting at the C. E. Unterberg, Towbin Emerging Growth Conference |
|
| 07/11/2005 |
|
DURECT Announces Start of Dosing in Cohort 3 of its Phase II Study for its Post-Operative Pain Relief Depot |
|
| 07/08/2005 |
|
DURECT Corporation Invites You to Join its Second Quarter 2005 Conference Call on the Web |
|
| 06/20/2005 |
|
DURECT Announces Preliminary Results from Cohort 2 of its On-Going Phase II Study for its Post-Operative Pain Relief Depot |
|
| 05/24/2005 |
|
DURECT Corporation Presenting at the Friedman Billings Ramsey 9th Annual Growth Investor Conference |
|
| 05/03/2005 |
|
DURECT Corporation Announces First Quarter 2005 Financial Results and Update on Its Development Programs |
|
| 04/19/2005 |
|
DURECT Corporation Invites You to Join its First Quarter 2005 Conference Call on the Web |
|
| 04/18/2005 |
|
Simon X. Benito Appointed to the Board of Directors of DURECT Corporation to Replace Albert L. Zesiger |
|
| 04/11/2005 |
|
DURECT Corporation Announces Planned Departure of CFO and Director Thomas A. Schreck |
|
| 03/29/2005 |
|
DURECT Corporation Presenting at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference |
|
| 03/14/2005 |
|
DURECT Corporation And Endo Pharmaceuticals Sign Agreement To Develop And Commercialize DURECT’s Seven-Day Transdermal Pain Patch |
|
| 02/24/2005 |
|
DURECT Corporation to Present at the Security Research Associates' Spring Technology & Life Sciences Investor Conference |
|
| 02/16/2005 |
|
DURECT Initiates Phase II Program for Its Sufentanil Patch Product |
|
| 02/10/2005 |
|
DURECT Completes Dosing of the Phase I Pharmacokinetic Study for Its Sufentanil Patch Product and of the First Cohort of the Phase II Study for Its Post-Operative Pain Relief Depot |
|
| 02/10/2005 |
|
DURECT Corporation Reports Fourth Quarter and Year End 2004 Financial Results |
|
| 01/28/2005 |
|
DURECT Corporation Announces Completion of Clinical Trial Enrollment for DURIN™-Based Leuprolide Product Candidate |
|
| 01/25/2005 |
|
DURECT Names Dr. Paula Mendenhall Senior Vice President of Operations |
|
| 01/20/2005 |
|
DURECT Corporation Invites You to Join its Fourth Quarter and Year-End 2004 Conference Call on the Web |
|
| 01/12/2005 |
|
DURECT Corporation Publishes Development Program Milestones for Fiscal Year 2005 |
|
| 01/05/2005 |
|
DURECT Corporation Presents an Update to Its Development Pipeline and Hosts 1st Analyst Luncheon |
|
| 12/23/2004 |
|
DURECT Corporation Announces Initiation of Phase III Studies for Remoxy, a Novel Oral Pain Medication using the ORADUR™ Gel-Cap |
|
| 12/20/2004 |
|
DURECT and Voyager Pharmaceutical Announce the Acceptance of DURIN™ Investigational New Drug Application and Clinical Protocol by the FDA for the Treatment of Alzheimer’s Disease |
|
| 11/22/2004 |
|
DURECT Corporation Presenting at the Lazard 1st Annual Life Sciences Conference |
|
| 11/04/2004 |
|
DURECT Corporation Presenting at the Fifteenth Annual CIBC Healthcare Conference |
|
| 10/25/2004 |
|
DURECT Corporation Announces Third Quarter 2004 Financial Results and Update on Its Development Programs |
|
| 10/25/2004 |
|
DURECT Initiates Phase II Clinical Program for Post-Operative Pain Relief Depot |
|
| 10/22/2004 |
|
DURECT Corporation Presenting at the C. E. Unterberg, Towbin Specialty Pharmaceutical Conference |
|
| 10/22/2004 |
|
DURECT Initiates Phase I Trial for Its Proprietary Transdermal Sufentanil Patch |
|
| 10/21/2004 |
|
DURECT Corporation Presenting at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference |
|
| 10/18/2004 |
|
DURECT Corporation Invites You to Join its Third Quarter 2004 Conference Call on the Web |
|
| 10/12/2004 |
|
DURECT Corporation Presenting at the HealthpointCapital Biomaterials Summit |
|
| 10/05/2004 |
|
DURECT Corporation Presenting at BIO Emerging Company Investor Forum |
|
| 09/16/2004 |
|
DURECT Corporation Presenting at the First Annual Merriman Curhan Ford & Co. Investor Summit |
|
| 08/09/2004 |
|
DURECT Corporation Presenting at the Halpern Capital Summer Growth Stock Conference |
|
| 08/02/2004 |
|
DURECT Corporation Presenting at the Adams Harkness & Hill’s 24th Summer Seminar |
|
| 07/21/2004 |
|
DURECT Corporation Announces Second Quarter 2004 Financial Results and Update on Its Development Programs |
|
| 07/15/2004 |
|
DURECT Corporation Invites You to Join its Second Quarter 2004 Conference Call on the Web |
|
| 07/06/2004 |
|
DURECT ANNOUNCES POSITIVE CLINICAL RESULTS WITH ITS ORADUR™ SUSTAINED RELEASE ORAL GEL-CAP TECHNOLOGY |
|
| 06/21/2004 |
|
DURECT Corporation and NeuroSystec Corporation Announce Exclusive Agreement to Develop Treatments for Certain Inner Ear Disorders Including Tinnitus |
|
| 05/06/2004 |
|
DURECT Corporation Presenting at the Rodman & Renshaw Healthcare Conference |
|
| 04/27/2004 |
|
DURECT Corporation Presenting at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference |
|
| 04/22/2004 |
|
DURECT Corporation Announces First Quarter 2004 Financial Results |
|
| 04/14/2004 |
|
DURECT Corporation Invites You to Join its First Quarter 2004 Conference Call on the Web |
|
| 03/23/2004 |
|
Michael D. Casey Appointed to the Board of Directors of DURECT Corporation |
|
| 02/24/2004 |
|
DURECT Corporation Presenting at the 4th Annual Smith Barney Citigroup Specialty Pharmaceuticals Conference |
|
| 02/13/2004 |
|
DURECT Announces Promotions and Management Changes |
|
| 02/10/2004 |
|
DURECT Corporation Reports Fourth Quarter 2003 and Year End Financial Results |
|
| 01/27/2004 |
|
DURECT Corporation Invites You to Join its Fourth Quarter and Year End 2003 Conference Call on the Web |
|
| 01/06/2004 |
|
DURECT Corporation Presenting at the JPMorgan H&Q 22nd Annual Healthcare Conference |
|
| 11/07/2003 |
|
DURECT Corporation Presenting at The CIBC World Markets 14th Annual Healthcare Conference |
|
| 11/06/2003 |
|
DURECT Announces Positive Clinical Results for its Post-operative Pain Relief Depot using the SABER™ Delivery System |
|
| 11/06/2003 |
|
DURECT Corporation Announces Third Quarter 2003 Financial Results |
|
| 10/20/2003 |
|
DURECT Corporation Invites You to Join its Third Quarter 2003 Conference Call on the Web |
|
| 10/16/2003 |
|
DURECT Announces Update to CHRONOGESIC Program |
|
| 10/09/2003 |
|
DURECT Initiates Manufacture of Clinical Product for its CHRONOGESIC® (sufentanil) Pain Therapy Product |
|
| 09/23/2003 |
|
Jon S. Saxe Appointed to the Board of Directors of DURECT Corporation |
|
| 09/03/2003 |
|
DURECT Corporation Presenting at the Thomas Weisel Partners Healthcare Conference |
|
| 09/02/2003 |
|
DURECT Corporation Completes Validation of Terminal Sterilization Manufacturing Process for its CHRONOGESIC (sufentanil) Pain Therapy Product |
|
| 08/05/2003 |
|
DURECT Corporation Presenting at the Adams Harkness & Hill’s 23rd Summer Seminar |
|
| 07/24/2003 |
|
DURECT Corporation Announces Second Quarter 2003 Financial Results |
|
| 07/11/2003 |
|
Initial Purchaser Exercises Option to Purchase an Additional $10 Million of the $50 Million of 6.25% Convertible Notes |
|
| 07/11/2003 |
|
DURECT Corporation Invites You to Join its Second Quarter 2003 Conference Call on the Web |
|
| 06/13/2003 |
|
DURECT Corporation Announces Pricing of $50 Million Convertible Note Offering |
|
| 06/11/2003 |
|
DURECT Corporation Announces Proposed $50 Million Convertible Debt Offering |
|
| 06/10/2003 |
|
DURECT Initiates Human Clinical Testing for its Post-operative Pain Relief Depot using the SABER™ Delivery System |
|
| 05/15/2003 |
|
DURECT Corporation Presenting at Friedman Billings Ramsey 7th Annual Technology & Growth Investor Conference |
|
| 04/28/2003 |
|
DURECT Corporation Presenting at The CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference |
|
| 04/28/2003 |
|
DURECT CORPORATION ANNOUNCES FIRST QUARTER 2003 FINANCIAL RESULTS |
|
| 04/15/2003 |
|
DURECT Corporation Invites You to Join its First Quarter 2003 Conference Call on the Web |
|
| 01/28/2003 |
|
DURECT Corporation Reports Fourth Quarter 2002 and Year End Financial Results |
|
| 01/15/2003 |
|
DURECT Corporation Invites You to Join its Fourth Quarter and Year End 2002 Conference Call on the Web |
|
| 01/14/2003 |
|
Pain Therapeutics And DURECT Corporation Announce Exclusive Agreement To Formulate Certain Long-Acting Opioid Drugs |
|
| 01/02/2003 |
|
DURECT Corporation Presenting at the JPMorgan H&Q 21st Annual Healthcare Conference |
|
| 12/27/2002 |
|
David R. Hoffmann Appointed to the Board of Directors of DURECT Corporation |
|
| 11/22/2002 |
|
DURECT Corporation Increases Focus on Product Development Activities and Reducing Costs |
|
| 11/19/2002 |
|
BioPartners and DURECT Corporation Enter into Agreement for Development of Sustained Release Interferon alpha |
|
| 11/14/2002 |
|
DURECT Corporation and Thorn BioScience LLC Expand Existing Licensing Agreement to Develop Veterinary Products |
|
| 11/12/2002 |
|
DURECT Corporation and ALZA Corporation Amend Licensing Agreement |
|
| 11/12/2002 |
|
DURECT Corporation Reports Third Quarter 2002 Financial Results |
|
| 11/11/2002 |
|
DURECT Corporation Postpones Its Third Quarter 2002 Conference Call |
|
| 11/11/2002 |
|
Endo Pharmaceuticals and DURECT Corporation Agree To Collaborate on Treatment in Pain Management |
|
| 10/30/2002 |
|
DURECT Corporation Presenting at The CIBC World Markets 13th Annual Health Care Conference |
|
| 10/16/2002 |
|
DURECT Corporation Invites You to Join its Third Quarter 2002 Conference Call on the Web |
|
| 10/04/2002 |
|
DURECT Corporation Presenting at The UBS Warburg Global Life Sciences Conference |
|
| 08/26/2002 |
|
DURECT Corporation Delays Enrolling Additional Patients in its Phase III Clinical Trial for CHRONOGESIC Pending Clinical Trial Protocol Amendments |
|
| 08/08/2002 |
|
DURECT Corporation Presenting at The Adams, Harkness & Hill’s 22nd Annual Summer Seminar |
|
| 07/29/2002 |
|
DURECT Corporation and Voyager Pharmaceutical Corporation Sign Development and Commercialization Agreement to Develop Treatment for Alzheimer's Disease |
|
| 07/29/2002 |
|
DURECT Corporation Reports Second Quarter 2002 Financial Results |
|
| 07/09/2002 |
|
DURECT Initiates Pivotal Phase III Program for the CHRONOGESIC™ (sufentanil) Pain Therapy System |
|
| 07/08/2002 |
|
DURECT Corporation Invites You to Join its Second Quarter 2002 Conference Call on the Web |
|
| 06/11/2002 |
|
DURECT Corporation to Present at the Goldman Sachs Twenty - Third Annual Global Healthcare Conference |
|
| 06/05/2002 |
|
DURECT Corporation Presenting at the UBS Warburg Global Specialty Pharmaceuticals Conference |
|
| 04/29/2002 |
|
DURECT Corporation Presenting at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference |
|
| 04/24/2002 |
|
DURECT Corporation Reports First Quarter 2002 Financial Results |
|
| 04/08/2002 |
|
DURECT Corporation Invites You to Join its First Quarter 2002 Conference Call on the Web |
|
| 04/02/2002 |
|
DURECT Corporation Files IND for the Long Term Treatment of Asthma |
|
| 03/27/2002 |
|
DURECT Corporation and Cardinal Health Announce Collaboration to Research and Develop Long Acting Gel-Cap Products Using The SABER™ Delivery System |
|
| 03/18/2002 |
|
DURECT Corporation Announces Positive Results of Pilot Phase III Study For The CHRONOGESIC™ Product |
|
| 01/30/2002 |
|
DURECT Corporation Reports Fourth Quarter 2001 and Year End Financial Results |
|
| 01/23/2002 |
|
DURECT Corporation Sponsors Symposium on Novel Drug Delivery Technologies at the 45th Annual Meeting of the Western Pharmacology Society (WPS) |
|
| 01/14/2002 |
|
DURECT Corporation Invites You to Join its Fourth Quarter and Year End 2001 Conference Call on the Web |
|
| 01/04/2002 |
|
DURECT Corporation Presenting at the JPMorgan H&Q 20th Annual Healthcare Conference |
|
| 11/16/2001 |
|
Janssen Pharmaceutica Enters into Exclusive Marketing Discussions with DURECT Corporation for Chronogesic™ |
|
| 11/01/2001 |
|
DURECT Corporation Presenting at the CIBC World Markets Twelfth Annual Health Care Conference |
|
| 11/01/2001 |
|
DURECT Corporation Reports Initiation of Phase III Program for Chronogesic™ |
|
| 10/31/2001 |
|
DURECT Corporation Reports Third Quarter 2001 Financial Results |
|
| 10/25/2001 |
|
DURECT Announces Results From Research Collaboration with the University of Maastricht Showing Blood Flow to the Ischemic Heart Restored Following Local Administration of Growth Factors |
|
| 10/16/2001 |
|
DURECT Corporation Presenting at the Techvest 3rd Annual Healthcare Conference |
|
| 10/15/2001 |
|
DURECT Corporation Invites You to Join its Third Quarter 2001 Conference Call on the Web |
|
| 09/24/2001 |
|
DURECT Corporation Announces Promotions of Officers |
|
| 09/05/2001 |
|
DURECT Announces Positive Phase II Results on Chronogesic™ for Long-Term Pain Relief |
|
| 08/24/2001 |
|
DURECT Corporation Invites You to Join its Phase II Trial Results Conference Call on the Web |
|
| 07/30/2001 |
|
DURECT Corporation Reports Second Quarter 2001 Financial Results |
|
| 07/19/2001 |
|
DURECT Corporation Invites You to Join its Second Quarter 2001 Conference Call on the Web |
|
| 07/06/2001 |
|
DURECT Corporation Adopts Stockholder Rights Plan |
|
| 06/29/2001 |
|
DURECT Announces Chronogesic™ Preliminary Clinical Results of Phase II Trial |
|
| 06/25/2001 |
|
DURECT Announces Filing of Special 510(k) Application for its New Generation IntraEAR® Ear Catheter Product And Approval of Physician Sponsored Investigational New Drug Application for Treatment of Meniere’s Disease |
|
| 05/24/2001 |
|
DURECT Completes Construction of Commercial Manufacturing Facility |
|
| 05/11/2001 |
|
DURECT Corporation Completes the Clinical Portion of Phase II Clinical Trial for DUROS Sufentanil |
|
| 04/30/2001 |
|
DURECT Corporation Reports First Quarter 2001 Financial Results |
|
| 04/30/2001 |
|
DURECT Corporation Announces Acquisition of Southern BioSystems, Inc. |
|
| 04/24/2001 |
|
DURECT Corporation Invites You to Join its First Quarter 2001 Conference Call on the Web |
|
| 04/03/2001 |
|
Dennis M. Fisher, MD Named Vice President for Medical Affairs |
|
| 03/27/2001 |
|
DURECT Corporation Announces Long-Term Drug Supply Agreement with Mallinckrodt |
|
| 03/09/2001 |
|
DURECT Corporation Announces Completion of Patient Enrollment in Phase II Clinical Trial for DUROS Sufentanil |
|
| 03/01/2001 |
|
Armand P. Neukermans Appointed to the Board of Directors of DURECT Corporation |
|
| 03/01/2001 |
|
DURECT Corporation Invites You to View Its Salomon Smith Barney Specialty Pharmaceuticals Conference Investor Presentation |
|
| 02/16/2001 |
|
DURECT Corporation Announces Earnings and Reports Strong Progress on Its Business |
|
| 02/07/2001 |
|
DURECT Announces Acceleration of Completion of Patient Enrollment in its Phase II Clinical Trial for DUROS® Sufentanil |
|
| 01/24/2001 |
|
Evelyn R. Robledo Named Vice President of Quality Assurance and Compliance |
|
| 01/22/2001 |
|
DURECT Corporation Invites You to Join its Fourth Quarter Conference Call on the Web |
|
| 12/11/2000 |
|
DURECT Corporation Enrolls Patients in Phase II Clinical Trial for DUROS® Sufentanil |
|
| 11/13/2000 |
|
DURECT Corporation Reports Third Quarter 2000 Financial Results |
|
| 11/07/2000 |
|
DURECT Corporation Invites You to Join its Third Quarter Conference Call on the Web |
|
| 11/02/2000 |
|
DURECT Corporation Announces Exercise of Over-allotment Option in Initial Public Offering |
|
| 10/23/2000 |
|
DURECT Corporation Announces Commencement of Construction of Commercial Manufacturing Facility in Cupertino, CA |
|
| 09/28/2000 |
|
DURECT Announces Initial Public Offering |
|
| 04/20/2000 |
|
DURECT Announces Filing of Registration Statement |
|
| 10/06/1999 |
|
DURECT Corporation Acquires IntraEAR, Inc. |
|
| 08/12/1999 |
|
Genetronics Announces Election of Dr. Felix Theeuwes, A Drug Delivery Pioneer, to Its Board of Directors |
|
| 08/02/1999 |
|
DURECT Corporation Receives $20 Million in Second Round of Funding |
|
